The pro-Israel lobby group funneled millions in donations to the campaigns of Israel’s strongest allies as Congress was voting on aid for the country’s war in Gaza.
by Donald Shaw, Sludge
The American Israel Public Affairs Committee delivered more than $3.7 million in November to the campaigns of U.S. lawmakers, the most it has ever doled out in a single month, according to a new filing with the Federal Election Commission.
The American Israel Public Affairs Committee (AIPAC) has been working to convince members of the U.S. Congress to send more aid to Israel for its war against Hamas and to support primary challengers against representatives and senators who it sees as not sufficiently supportive of Israel’s response to the October 7 Hamas attack.

The largest recipient of AIPAC’s campaign support in November, which came by way of its PAC, was New York Democrat Rep. Ritchie Torres, who was profiled by the New York Times in November as an example of a young Democratic politician who has sided firmly with Israel, as opposed to those in the so-called “squad” of progressives who have spoken critically of the country’s military actions. AIPAC sent Torres more than $201,000 in donations from its PAC in November, according to the filing.
Recent Posts
Donald Trump’s Tariffs Are Raised Taxes On Working People
March 4, 2025
Take Action Now Trump’s tariffs on Canada and Mexico will hit working Americans hard. Will they sour on his policies?By Dean Baker, CEPR The…
Third Way And Its Regressive Politics Should Have No Place In The Democratic Party
March 4, 2025
Take Action Now Third Way has a new set of prescriptions for the Democratic Party. Unfortunately, they sound a lot like the Republican Party.By…
Liberal Delusions Won’t Save Ukraine
March 3, 2025
Take Action Now For some liberals, Donald Trump’s decision to humiliate Volodymyr Zelensky showed that he’s a Russian stooge. But Trump’s crudeness…
AOC Blasts GOP For Letting Elon Musk Killing Drug Pricing Reform
March 3, 2025
Take Action Now She slammed the Republican Party for allowing Elon Musk to derail bipartisan drug pricing reforms, calling the move a clear example…